VRDN vs RXRX
Comparison between Viridian Therapeutics Inc (VRDN, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).
Both VRDN and RXRX are from the Healthcare sector.
5-Year PerformanceVRDN has outperformed RXRX, delivering a return of +0.1% compared to -36.8%
VRDN vs RXRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
VRDN vs RXRX - Historical Returns
Returns include dividend reinvestment.
VRDN vs RXRX - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | VRDN | RXRX |
|---|---|---|
| 2026 | -46.71% | -25.00% |
| 2025 | +57.49% | -43.27% |
| 2024 | -14.23% | -31.51% |
| 2023 | -23.58% | +30.60% |
| 2022 | +40.77% | -57.24% |
| 2021 | +14.94% | -45.27% |
| 2020 | +115.88% | N/A |
| 2019 | -85.71% | N/A |
| 2018 | -70.61% | N/A |
| 2017 | +102.52% | N/A |
| 2016 | -53.61% | N/A |
| 2015 | -69.47% | N/A |
| 2014 | -72.06% | N/A |
VRDN vs RXRX Drawdown Comparison
The maximum drawdown for VRDN was -99.73%, occurring on Mar 19, 2020. This drawdown has not yet recovered.
The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current VRDN drawdown is -99.20%. The current RXRX drawdown is -92.38%.
| Rank | VRDN | RXRX |
|---|---|---|
| #1 | -99.73% Jun 18, 2014 - Mar 19, 2020 | -93.13% Jul 13, 2021 - Mar 30, 2026 |
| #2 | N/A | -38.10% Apr 29, 2021 - Jun 17, 2021 |
| #3 | N/A | -10.54% Apr 16, 2021 - Apr 21, 2021 |
| #4 | N/A | -10.45% Jun 21, 2021 - Jul 6, 2021 |
| #5 | N/A | -8.29% Apr 21, 2021 - Apr 29, 2021 |
Correlation
Correlation between VRDN and RXRX is -0.15 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks